Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 402385, 10 pages
http://dx.doi.org/10.1155/2015/402385
Research Article

Auraptene, a Major Compound of Supercritical Fluid Extract of Phalsak (Citrus Hassaku Hort ex Tanaka), Induces Apoptosis through the Suppression of mTOR Pathways in Human Gastric Cancer SNU-1 Cells

1Subtropical Horticulture Research Institute, Jeju National University, Jeju 690-756, Republic of Korea
2Faculty of Biotechnology, College of Applied Life Science, SARI, Jeju National University, Jeju 690-756, Republic of Korea

Received 19 April 2015; Revised 21 June 2015; Accepted 15 July 2015

Academic Editor: Brett Froeliger

Copyright © 2015 Jeong Yong Moon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Liu, Z. Li, S. Bai et al., “Mechanism of cancer cell adaptation to metabolic stress: proteomics identification of a novel thyroid hormone-mediated gastric carcinogenenic signaling pathway,” Molecular and Cellular Proteomics, vol. 8, no. 1, pp. 70–85, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Plummer, S. Franceschi, and N. Muñoz, “Epidemiology of gastric cancer,” IARC Scientific Publications, vol. 157, pp. 311–326, 2004. View at Google Scholar · View at Scopus
  3. P. Yang, Y. Zhou, B. Chen et al., “Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies,” European Journal of Cancer, vol. 45, no. 16, pp. 2867–2873, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Lunet, C. Valbuena, A. L. Vieira et al., “Fruit and vegetable consumption and gastric cancer by location and histological type: case-control and meta-analysis,” European Journal of Cancer Prevention, vol. 16, no. 4, pp. 312–327, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. M.-C. Lin, M.-J. Tsai, and K.-C. Wen, “Supercritical fluid extraction of flavonoids from Scutellariae Radix,” Journal of Chromatography A, vol. 830, no. 2, pp. 387–395, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Kawaii, Y. Tomono, E. Katase, K. Ogawa, and M. Yano, “Antiproliferative activity of flavonoids on several cancer cell lines,” Bioscience, Biotechnology and Biochemistry, vol. 63, no. 5, pp. 896–899, 1999. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Sahebkar, “Citrus auraptene: a potential multifunctional therapeutic agent for nonalcoholic fatty liver disease,” Annals of Hepatology, vol. 10, no. 4, pp. 575–577, 2011. View at Google Scholar · View at Scopus
  8. H. Kohno, R. Suzuki, M. Curini et al., “Dietary administration with prenyloxycoumarins, auraptene and collinin, inhibits colitis-related colon carcinogenesis in mice,” International Journal of Cancer, vol. 118, no. 12, pp. 2936–2942, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Hara, K. Sakata, Y. Yamada et al., “Suppression of beta-catenin mutation by dietary exposure of auraptene, a citrus antioxidant, in N,N-diethylnitrosamineinduced hepatocellular carcinomas in rats,” Oncology Reports, vol. 14, no. 2, pp. 345–351, 2005. View at Google Scholar · View at Scopus
  10. A. Murakami, W. Kuki, Y. Takahashi et al., “Auraptene, a Citrus coumarin, inhibits 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion in ICR mouse skin, possibly through suppression of superoxide generation in leukocytes,” Japanese Journal of Cancer Research, vol. 88, no. 5, pp. 443–452, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Murakami, Y. Nakamura, T. Tanaka et al., “Suppression by citrus auraptene of phorbol ester-and endotoxin-induced inflammatory responses: role of attenuation of leukocyte activation,” Carcinogenesis, vol. 21, no. 10, pp. 1843–1850, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Y. Jun, J. S. Kim, H. S. Park et al., “Apoptogenic activity of auraptene of Zanthoxylum schinifolium toward human acute leukemia Jurkat T cells is associated with ER stress-mediated caspase-8 activation that stimulates mitochondria-dependent or -independent caspase cascade,” Carcinogenesis, vol. 28, no. 6, pp. 1303–1313, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Curini, G. Cravotto, F. Epifano, and G. Giannone, “Chemistry and biological activity of natural and synthetic prenyloxycoumarins,” Current Medicinal Chemistry, vol. 13, no. 2, pp. 199–222, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Ulukaya, C. Acilan, and Y. Yilmaz, “Apoptosis: why and how does it occur in biology?” Cell Biochemistry and Function, vol. 29, no. 6, pp. 468–480, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. G. M. Kamal, F. Anwar, A. I. Hussain, N. Sarri, and M. Y. Ashraf, “Yield and chemical composition of Citrus essential oils as affected by drying pretreatment of peels,” International Food Research Journal, vol. 18, no. 4, pp. 1275–1282, 2011. View at Google Scholar · View at Scopus
  16. J. R. Patil, G. K. Jayaprakasha, K. N. Chidambara Murthy, S. E. Tichy, M. B. Chetti, and B. S. Patil, “Apoptosis-mediated proliferation inhibition of human colon cancer cells by volatile principles of Citrus aurantifolia,” Food Chemistry, vol. 114, no. 4, pp. 1351–1358, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Elmore, “Apoptosis: a review of programmed cell death,” Toxicologic Pathology, vol. 35, no. 4, pp. 495–516, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. X.-M. Sun, M. MacFarlane, J. Zhuang, B. B. Wolf, D. R. Green, and G. M. Cohen, “Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis,” The Journal of Biological Chemistry, vol. 274, no. 8, pp. 5053–5060, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. S. A. Amundson, T. G. Myers, and A. J. Fornace Jr., “Roles for p53 in growth arrest and apoptosis: Putting on the brakes after genotoxic stress,” Oncogene, vol. 17, no. 25, pp. 3287–3299, 1998. View at Google Scholar · View at Scopus
  20. A.-C. Gingras, B. Raught, and N. Sonenberg, “mTOR signaling to translation,” Current Topics in Microbiology and Immunology, vol. 279, pp. 169–197, 2003. View at Google Scholar · View at Scopus
  21. C. M. Maya-Monteiro and P. T. Bozza, “Leptin and mTOR: partners in metabolism and inflammation,” Cell Cycle, vol. 7, no. 12, pp. 1713–1717, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. C. M. Maya-Monteiro, P. E. Almeida, H. D'Ávila et al., “Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism,” The Journal of Biological Chemistry, vol. 283, no. 4, pp. 2203–2210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. S. H. Um, F. Frigerio, M. Watanabe et al., “Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity,” Nature, vol. 431, no. 7005, pp. 200–205, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. B. D. Manning, “Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis,” Journal of Cell Biology, vol. 167, no. 3, pp. 399–403, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. S.-Y. Sun, L. M. Rosenberg, X. Wang et al., “Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition,” Cancer Research, vol. 65, no. 16, pp. 7052–7058, 2005. View at Publisher · View at Google Scholar · View at Scopus